Peptide-tunable drug cytotoxicity via one-step assembled polymer nanoparticles

Advanced Materials

Volumn 26, Issue 15, 2014, Pages 2398-2402

  Liang, Kang ^a   Richardson, Joseph J ^a   Ejima, Hirotaka ^a   Such, Georgina K ^a   Cui, Jiwei ^a   Caruso, Frank ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

biomaterials; co delivery; drug delivery; peptide; self assembly

Indexed keywords

BIOLOGICAL MATERIALS; BIOMATERIALS; BLENDING; CYTOTOXICITY; DRUG DELIVERY; SELF ASSEMBLY;

BLENDING PROCESS; CELL-PENETRATING PEPTIDE; CHEMOTHERAPEUTIC DRUGS; CO DELIVERIES; MONO-DISPERSE; PEPTIDE LOADING; POLYMER BUILDING BLOCKS; POLYMER NANOPARTICLES;

PEPTIDES;

ANTINEOPLASTIC ANTIBIOTIC; DOXORUBICIN; DRUG CARRIER; MACROGOL DERIVATIVE; NANOPARTICLE; PEPTIDE; POLY(2-(DIISOPROPYLAMINO)ETHYL METHACRYLATE); POLYMER; POLYMETHACRYLIC ACID DERIVATIVE;

CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; HELA CELL LINE; HUMAN; PH;

ANTIBIOTICS, ANTINEOPLASTIC; CELL SURVIVAL; DOXORUBICIN; DRUG CARRIERS; HELA CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; NANOPARTICLES; PEPTIDES; POLYETHYLENE GLYCOLS; POLYMERS; POLYMETHACRYLIC ACIDS;

EID: 84898920606     PISSN: 09359648     EISSN: 15214095     Source Type: Journal    
DOI: 10.1002/adma.201305002     Document Type: Article

References (28)

1. a) V. P. Torchilin, Nat. Rev. Drug Discov. 2005, 4, 145
2. b) D. C. Drummond, O. Meyer, K. Hong, D. B. Kirpotin, D. Papahadjopoulos, Pharmacol. Rev. 1999, 51, 691
3. c) T. Lammers, W. E. Hennink, G. Storm, Br. J. Cancer 2008, 99, 392.
4. a) Y. Wang, S. Gao, W.-H. Ye, H. S. Yoon, Y.-Y. Yang, Nat. Mater. 2006, 5, 791
5. b) M. Khan, Z. Y. Ong, N. Wiradharma, A. B. E. Attia, Y.-Y. Yang, Adv. Healthcare Mater. 2012, 1, 373
6. c) S. Chen, D. Zhao, F. Li, R.-X. Zhuo, S.-X. Cheng, RSC Adv. 2012, 2, 1820
7. d) M. Creixell, N. A. Peppas, Nano Today 2012, 7, 367.
8. a) I. Nakase, Y. Konishi, M. Ueda, H. Saji, S. Futaki, J. Controlled Release 2012, 159, 181
9. b) V. P. Torchilin, Pept. Sci. 2008, 90, 604
10. c) N. Ferrer-Miralles, E. Vázquez, A. Villaverde, Trends Biotechnol. 2008, 26, 267-275
11. d) S. Futaki, Pept. Sci. 2006, 84, 241
12. e) Z. Poon, D. Chang, X. Zhao, P. T. Hammond, ACS Nano 2011, 5, 4284.
13. a) E. Vivès, J. Schmidt, A. Pèlegrin, Biochim. Biophys. Acta, Rev. Cancer 2008, 1786, 126
14. b) J. Regberg, A. Srimanee, Ü. Langel, Pharmaceuticals 2012, 5, 991
15. c) E. Vázquez, N. Ferrer-Miralles, A. Villaverde, Drug Discovery Today 2008, 13, 1067
16. d) F. Heitz, M. C. Morris, G. Divita, Br. J. Pharmacol. 2009, 157, 195.
17. K. Melikov, L. V. Chernomordik, Cell. Mol. Life Sci. 2005, 62, 2739.
18. V. A. Sethuraman, Y. H. Bae, J. Controlled Release 2007, 118, 216.
19. a) B. Langlet-Bertin, C. Leborgne, D. Scherman, B. Bechinger, A. J. Mason, A. Kichler, Pharm. Res. 2010, 27, 1426
20. b) P. Midoux, A. Kichler, V. Boutin, J.-C. Maurizot, M. Monsigny, Bioconjugate Chem. 1998, 9, 260.
21. D. Putnam, C. A. Gentry, D. W. Pack, R. Langer, Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 1200.
22. a) J. Du, S. P. Armes, J. Am. Chem. Soc. 2005, 127, 12800
23. b) K. Liang, G. K. Such, Z. Zhu, Y. Yan, H. Lomas, F. Caruso, Adv. Mater. 2011, 23, H273.
24. J. R. Casey, S. Grinstein, J. Orlowski, Nat. Rev. Mol. Cell Biol. 2010, 11, 50.
25. K. Liang, G. K. Such, Z. Zhu, S. J. Dodds, A. P. R. Johnston, J. Cui, H. Ejima, F. Caruso, ACS Nano 2012, 6, 10186.
26. D. E. Discher, A. Eisenberg, Science 2002, 297, 967.
27. V. L. Jaspreet, K. Vasir, Technol. Cancer Res. Treat. 2005, 4, 363.
28. T. Mosmann, J. Immunol. Methods 1983, 65, 55.